FIELD: medicine.
SUBSTANCE: invention concerns medicine, namely application of sodium thiosulphate as a hypolipidemic and antiatherosclerotic agent for oral introduction to treat dislipoproteinemia and atherosclerosis.
EFFECT: there is disclosed hypolipidemic and antiatherosclerotic agent.
5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT WITH HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTION | 2008 |
|
RU2372897C1 |
| AGENT POSSESSING HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTIVITY | 2015 |
|
RU2598347C1 |
| HYPOLIPIDEMIC AGENT | 2008 |
|
RU2392933C2 |
| AGENT WITH HYPOLIPIDEMIC ACTIVITY | 2004 |
|
RU2268714C1 |
| AGENT FOR METABOLIC SYNDROME CORRECTION | 2011 |
|
RU2458935C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING HEPATOPROTECTING, HYPOLIPIDEMIC, IMMUNOSTIMULATING AND NORMALISING KIDNEY FUNCTION ACTION, AND METHOD OF ITS OBTAINING | 2011 |
|
RU2483712C2 |
| METHOD FOR DIAGNOSING LIPIDEMIA | 2019 |
|
RU2694531C1 |
| METHOD FOR ASSESSING THE EFFECTIVENESS OF THE TREATMENT OF LIPIDEMIA | 2019 |
|
RU2694534C1 |
| DIAGNOSTIC TECHNIQUE FOR EARLY AND LATE STAGES OF LIPIDEMIA | 2019 |
|
RU2694538C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF LIPIDEMIA | 2019 |
|
RU2714689C1 |
Authors
Dates
2009-11-20—Published
2007-08-27—Filed